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Abstract
Targeted sequencing is a cost-efficient way to obtain answers to biological questions in many projects, but the choice of the
enrichment method to use can be difficult. In this study we compared two hybridization methods for target enrichment for
massively parallel sequencing and single nucleotide polymorphism (SNP) discovery, namely Nimblegen sequence capture
arrays and the SureSelect liquid-based hybrid capture system. We prepared sequencing libraries from three HapMap
samples using both methods, sequenced the libraries on the Illumina Genome Analyzer, mapped the sequencing reads back
to the genome, and called variants in the sequences. 74–75% of the sequence reads originated from the targeted region in
the SureSelect libraries and 41–67% in the Nimblegen libraries. We could sequence up to 99.9% and 99.5% of the regions
targeted by capture probes from the SureSelect libraries and from the Nimblegen libraries, respectively. The Nimblegen
probes covered 0.6 Mb more of the original 3.1 Mb target region than the SureSelect probes. In each sample, we called
more SNPs and detected more novel SNPs from the libraries that were prepared using the Nimblegen method. Thus the
Nimblegen method gave better results when judged by the number of SNPs called, but this came at the cost of more over-
sampling.
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Introduction
Recent development of massively parallel sequencing technol-
ogies has remarkably increased the throughput and brought down
the costs of sequencing [1,2]. As a result, it is currently feasible to
sequence even whole human genomes in a time frame of months,
or even weeks, rather than years [3,4,5,6,7]. Though possible,
whole genome sequencing is still more laborious, time consuming,
and expensive than sequencing sub-regions of the genome. Data
analysis is also simplified by concentrating on specific sub-regions
of the genome. Thus in many projects, targeted sequencing of
specific regions of interest in a large number of samples continues
to be much more cost-effective in providing answers to biological
questions than sequencing the whole genomes of fewer individuals.
Targeted sequencing of all human exons has already led to the
discovery of a growing number of genes behind inherited disorders
[8,9,10,11,12,13], brain malformations [14], and cancer metastasis
[15]. In addition to selecting regions of genomic DNA, target
enrichment combined with massively parallel sequencing has a
number of other applications. It has been used for sequencing
RNA (cDNA) to study subsets of the transcriptome [16] as well as
studying RNA editing [17], allele specific gene expression [18],
and DNA methylation [19].
Several approaches have been developed to select the regions of
interest for sequencing from the genome [20]. Polymerase chain
reaction (PCR) has traditionally been used to enrich the genomic
fragments for Sanger sequencing. PCR selection of 144 target
regions in pooled DNA samples has been used successfully in
combination with massively parallel sequencing to discover new
SNPs associated with type 1 diabetes [21], but in addition to
becoming laborious and expensive when used for the enrichment
of larger genomic regions, even the combination of multiplex and
long-range PCR does not match the current throughput of the
massively parallel sequencing technologies. Thus a lot of effort has
recently been put into the development of more efficient
enrichment methods.
Hybrid selection using cDNA [22] and bacterial artificial
chromosomes (BACs) [23] have been used for selecting specific
genomic regions even before the development of massively parallel
sequencing technologies. DNA capture using concatenated PCR
products immobilized on filters as subgenomic traps [24] and
multicycle hybridization on microfluidic chips [25] were recently
described, but these methods are only scalable for enriching
regions of up to one megabase in size. Microdroplet-based PCR
enrichment has been successfully used for targeting 435 exons of
47 genes [26]. The Gene Collector method [27], selector probes
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produced by array-released oligo libraries [30,31] are enrichment
techniques, in which the target DNA is circularized by a hybrid
selection step followed by a ligation step and then amplified. In
array based hybridization capture methods, hundreds of thousands
of oligonucleotides complementary to the region of interest are
synthesized on high-density DNA microarrays [32,33,34,35]. In
the solution based hybridization capture method, array-released
oligo libraries are converted into biotinylated in vitro transcribed
RNA probes, which are used to capture the regions of interest
[36,37]. These methods are suitable for the enrichment of large
genomic regions, including whole exomes.
Our goal was to choose the optimal enrichment method for
variant discovery in continuous custom-selected target regions.
The choice of the Nimblegen array and SureSelect solution based
hybridization capture methods for the comparison presented here
was based on their throughput and general availability. In order to
evaluate these methods, we prepared sequencing libraries from
three HapMap samples using both methods for the same target
region and sequenced the libraries using a Genome Analyzer IIx
instrument (Illumina). We called sequence variants and compared
the results to the existing data for the HapMap samples as well as
to data in publicly available databases and validated the findings
by Sanger sequencing.
Materials and Methods
Samples
DNA samples from three immortalized lymphoblastoid cell
lines, NA10860, NA11992, and NA11993, were purchased from
the Coriell Cell repository (Camden, NJ).
Nimblegen array hybridization
The protocol was modified from previous descriptions [33,34].
Fifteen mg of genomic DNA in 100 ml TE-buffer was first sonicated
using cycles of 30 s on and 30 s off for a total of 15 min with high
power in a water bath sonicator (Bioruptor, Diagenode) to obtain
fragments of ,800 bp. The fragmentation efficiency was evalu-
ated by capillary electrophoresis on DNA1000 chips (Agilent 2100
Bioanalyzer, Agilent). Sequencing adapters were ligated on the
DNA fragments according to manufacturer’s instructions (Illu-
mina). Three parallel reactions were done for each sample. To
obtain blunt ended fragments, 45 mlo fH 2O, 10 ml of T4 DNA
ligase buffer with 10 mM ATP (New England Biolabs (NEB)), 4 ml
10 mM dNTP mix (Invitrogen), 5 ml T4 DNA polymerase (NEB),
1 ml Klenow DNA polymerase (NEB), and 4 ml T4 polynucleotide
kinase (NEB) were added to 5 mg of fragmented DNA in 30 mlE B
(Qiagen) and incubated for 30 min at 20uC. The reaction product
was purified with the QIAquick PCR purification kit (Qiagen) and
the DNA was eluted into 32 ml of EB. To add A bases to the 39
ends of the DNA fragments, 5 ml of NEB2 buffer (NEB), 10 ml
1 mM dATP, and 3 ml Klenow exo- (NEB) were added to the
DNA and incubated for 30 min at 37uC. The reaction product
was purified with the MinElute PCR purification kit (Qiagen) and
eluted into 10 ml EB. Adapters were ligated to the ends of the
DNA fragments by adding 25 ml Quick ligase buffer (NEB), 10 ml
adapter oligo mix (Illumina), and 5 ml Quick ligase (NEB) and
incubating for 15 min at 20uC. The reaction product was purified
with the QIAquick PCR purification kit (Qiagen) and eluted into
30 ml EB. The three reaction products were pooled and the
quantity of the adapter ligated DNA was measured with a
Nanodrop ND-1000 spectrophotometer (Nanodrop Technolo-
gies). Fifty mg of human Cot-1 DNA (Invitrogen) and 1 mmol of
each blocking oligo (complementary to the sequencing adapters;
IDT) were added to the adapter ligated DNA. The samples were
dried in a DNA120 SpeedVac concentrator (Thermo Electron),
rehydrated with 4.8 mlH 2O and incubated for 10 min at 70uC.
Eight ml of 2xSC hybridization buffer (Roche Nimblegen) and
3.2 ml SC hybridization component A (Roche Nimblegen) were
added to the rehydrated DNA. The DNA was denatured for
10 min at 95uC and then kept at 42uC until it was loaded onto the
arrays. Fifteen ml of the sample was loaded on the 385K feature
custom designed sequence capture arrays (Roche Nimblegen) and
incubated for 65 hours with mixing at 42uC. After the hybridiza-
tion, the slide was washed once in wash buffer II (Roche
Nimblegen) at room temperature (RT), twice with stringent wash
buffer (Roche Nimblegen) for 5 min at 47.5uC, once with wash
buffer I (Roche Nimblegen) for 2 min with 1 inversion/s at RT,
once with wash buffer II (Roche Nimblegen) for 1 min with 1
inversion/s at RT, and once with wash buffer III (Roche
Nimblegen) with 10 inversions at RT. DNA was eluted from the
arrays, twice for 5 min at 95uC, and once without incubation with
400 mlH 2O. All three eluates were collected in the same tube and
the sample dried in a DNA120 SpeedVac concentrator (Thermo
Electron). The sample was rehydrated with 20 mlo fH 2O. Three
ml of the rehydrated elution product was used for the subsequent
PCR with adapter-primers. The PCR reaction mixture also
contained 1 ml primer 1.1 (Illumina), 1 ml primer 2.1 (Illumina),
25 ml Phusion master mix (Finnzymes), and 20 mlH 2O. The PCR
was performed as follows: 30 s at 98uC, 18 cycles of: 10 s at 98uC,
30 s at 65uC, and 30 s at 72uC, then 5 min at 72uC. The PCR
product was purified with the QIAquick PCR purification kit
(Qiagen) and eluted into 30 ml EB. The quality of the sequencing
libraries was verified by capillary electrophoresis (Bioanalyzer,
Agilent).
SureSelect hybridization
SureSelect sequencing libraries were prepared according to the
manufacturer’s instructions (Agilent). Three mg of genomic DNA
in 100 ml TE-buffer was fragmented to a median size of 200 bp
using the Covaris-S2 instrument (Covaris) with the following
settings: duty cycle 10%, intensity 5, cycles per burst 200, and
mode frequency sweeping for 180 s at 4uC. The fragmentation
efficiency was evaluated by capillary electrophoresis on DNA1000
chips (Agilent). Sequencing adapters were ligated on the DNA
fragments following the manufacturer’s protocol (Illumina) as
described above for the Nimblegen method. Adapter ligated DNA
was run on a 2% TAE-agarose gel (BioRad) and the region of the
gel containing fragments in the 200–300 bp range was excised.
The DNA was purified from the gel using a Gel extraction kit
(Qiagen) and eluted in 30 ml EB. The adapter ligated and size
selected DNA was amplified by PCR. One ml of DNA, 22 mlH 2O,
1 ml primer 1.1 (Illumina), 1 ml primer 2.1 (Illumina), and 25 ml
Phusion master mix (Finnzymes) were amplified as follows: 30 s at
98uC, 14 cycles of: 10 s at 98uC, 30 s at 65uC, and 30 s at 72uC,
then 5 min at 72uC. The reaction product was purified with the
QIAquick PCR purification kit (Qiagen) and eluted into 50 ml EB.
The quality of the PCR products was assessed by capillary
electrophoresis (Bioanalyzer, Agilent). SureSelect hyb #1, #2,
#3, and #4 reagents (Agilent) were mixed to prepare the
hybridization buffer. The adapter ligated DNA fragments were
concentrated in a DNA120 SpeedVac concentrator (Thermo
Electron) to 500 ng in 3.4 ml. SureSelect block #1, #2, and #3
reagents (Agilent) were added to the 500 ng of DNA. The
hybridization buffer and the DNA blocker mix were incubated for
5 min at 95uC and then for 10 min at 65uC in a thermal cycler
(MJ Research). RNase block (Agilent) was added to the SureSelect
oligo capture library (Agilent). The capture library was incubated
Target Enrichment Method Comparison
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DNA blocker mix were added to the capture library and the
mixture was incubated for 24 hours at 65uC in a thermal cycler
(MJ Research). Fifty ml of streptavidin coated Dynabeads M-280
(Invitrogen) were washed three times with 200 ml SureSelect
binding buffer (Agilent) and resuspended in 200 ml of the binding
buffer. The hybridization mixture was added to the bead
suspension and incubated for 30 min at RT with mixing. The
beads were washed with 500 ml SureSelect wash buffer #1
(Agilent) for 15 min at RT, and three times with 500 ml SureSelect
wash buffer #2 (Agilent) for 10 min at 65uC. DNA was eluted
with 50 ml SureSelect elution buffer (Agilent) for 10 min at RT.
Fifty ml of SureSelect neutralization buffer (Agilent) was added to
the eluted DNA. The reaction product was purified with the
MinElute PCR purification kit (Qiagen) eluting in 15 ml EB. Two
PCR reactions with 1 ml of the elution product, 1 ml primer 1.1
(Illumina), 1 ml primer 2.1 (Illumina), 25 ml Phusion master mix
(Finnzymes), and 22 mlH 2O were performed. The PCR
conditions were as follows: 30 s at 98uC, 18 cycles of: 10 s at
98uC, 30 s at 65uC, and 30 s at 72uC, then 5 min at 72uC. The
two reactions were combined and purified with the QIAquick
PCR purification kit (Qiagen) and eluted into 30 ml EB. The
quality of the sequencing libraries was verified by capillary
electrophoresis (Bioanalyzer, Agilent) and the concentration was
measured with a spectrophotometer (NanoDrop Technologies).
Sequencing by the Genome Analyzer IIX
Samples were sequenced on the Illumina Genome Analyzer IIX
(GAIIX) following the manufacturer’s instructions. A single read
cluster generation kit v.2 (Illumina) was used to generate the
clusters and a single read sequencing kit v.3 (Illumina) was used for
sequencing. All samples were sequenced on a single lane of an
Illumina flow cell in the same single read 36 cycle GA run.
Data analysis
Image analysis and base calling of the raw sequencing data were
performed using the Illumina data analysis pipeline v1.4. The
sequences were aligned to the human genome reference (hg18,
build 36) using BWA [38] with default parameters. The sequence
reads that aligned to the targeted regions were then extracted from
the BWA alignment using Samtools [39]. The extracted sequence
reads were re-aligned to the targeted regions using Maq [40] with
default parameters in order to perform SNP calling. In house
scripts written in Perl were used for the downstream analyses of the
obtained SNP lists as well as for making the coverage plots. The
HapMap data used was the Feb 2009 phaseII+III data
downloaded from the NCBI ftp-site (ftp.ncbi.nlm.nih.gov:/hap-
map/genotypes/2009-02_phaseII+III/forward/non-redundant/).
Plink [41] was used for inheritance analysis of novel SNPs.
Sanger sequencing
PCR primers were designed using Primer3 (http://frodo.wi.mit.
edu/primer3/) and Autoprimer (http://www.autoprimer.com,
Beckman Coulter Inc.) and ordered from Integrated DNA
Technology (IDT). Primer sequence information is available in
Supplementary Table S1. Twenty ng of genomic DNA was
amplified with 0.05 mM primers, 0.1 U/mL SmartTaq DNA
polymerase (Naxo) and 80 mM dNTPs in 10 mM Tris–HCl,
pH 8.8, 50 mM KCl, 5 mM MgCl2, 0.001% (w/v) gelatin in a
reaction volume of 10 mla t9 5 uC for 7 min, 40 cycles of 94uC for
30 s, 55 or 60.5uC for 30 s and 72uC for 1 min. Amplification
products were verified on 1.5% agarose gels and 7 ml of each
product was incubated with 0.5 U/mL exonuclease I (Fermentas),
and 0.1 U/mL shrimp alkaline phosphatase (GE Healthcare) in
10 ml of 48 mM Tris–HCl, pH 9.5, 7.6 mM MgCl2,a t3 7 uC for
45 min, followed by inactivation of the enzymes at 85uC for
15 min. Purified PCR products were split into two reactions and
sequenced on both strands (ABI3730XL, Applied Biosystems).
The resulting traces were analyzed with the Sequence Scanner
v.1.0 software (Applied Biosystems).
Results
Capture probe designs
To compare the performance of two generally available
hybridization-based methods for capturing 56 genes, including
exons, introns, and 5 kb of up- and downstream non-coding
sequence for massively parallel sequencing, we ordered assays
from two companies, Agilent and Roche Nimblegen. For each
gene, the transcribed region was determined according to the
longest annotation of the transcript in the consensus coding
sequence regions (CCDS) database and the region was extended
with 5 kb upstream and downstream of the transcript. Put
together, these 56 gene regions of 13–234 kb in size made up a
region of interest of 3.1 Mb in total size. The probe designs
obtained from the companies were uploaded in the UCSC
genome browser (http://genome.ucsc.edu/) and the probe
positions were checked manually before acceptance. In the
SureSelect method from Agilent, biotinylated RNA probes of
120 nucleotides in length are used to capture the desired DNA
fragments from a pool of DNA fragments to which sequencing
adapters have been ligated [36]. In the design that we ordered,
each target position was covered by four different probes resulting
in 30 bp offset between the probes. Agilent used RepeatMasker
(http://www.repeatmasker.org/) to exclude repeated regions from
the SureSelect design, which resulted in a probe set that targets
1.7 Mb (55%) of the original regions of interest. In the Nimblegen
sequence capture method, the probes used are oligonucleotides
synthesized on microarray slides. The length of the probes is
adjusted to yield a uniform melting temperature (Tm). In our
design, the capture probes tile the region of interest with five base
pair offset. Repeats were excluded from the design based on in-
house repeat masking at Nimblegen [34], which resulted in a
probe set that targets 2.4 Mb (78%) of the original target regions.
1.6 Mb (53%) of the original 3.1 Mb target region was targeted by
both probe sets.
Sequencing and alignment
We prepared sequencing libraries from three HapMap samples
(NA10860, NA11992, and NA11993) using both the SureSelect
target enrichment system from Agilent and the 385K sequence
capture arrays from Roche Nimblegen using their standard
protocols, and sequenced them in the same Genome Analyzer
36 bp single-read run. We obtained 10 to 13.4 million reads from
the libraries prepared with the Nimblegen method and 18.3 to
19.1 million reads from the libraries prepared with the SureSelect
method (Table 1). We were able to obtain more sequence reads
from the SureSelect libraries since they had ,14-fold higher
concentrations than the Nimblegen array captured libraries, which
made the quantification of the SureSelect libraries more accurate,
which in turn resulted in optimal DNA amounts being deposited
on the flow-cell for sequencing and higher cluster density.
The error rate estimated by the Illumina GA-pipeline was
approximately 0.3% based on an ELAND-alignment against the
human genome reference sequence (hg18, build 36). Out of the
sequence reads that passed the quality filter in the Illumina data
analysis pipeline, 83 to 90% aligned to the human genome
reference (Table 1). For the subsequent analysis, the sequence
Target Enrichment Method Comparison
PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e16486reads were re-aligned against the human genome reference using
BWA [38]. BWA places the reads that align to multiple locations
randomly to one of those locations. When the reads mapping to
the target region were extracted from the alignment using
Samtools [39], the reads that mapped to multiple locations, but
had been randomly placed to our target region by BWA, were
included. Between 41 and 75% of the quality filtered reads aligned
to the target regions per sample (Table 1). In each sample, a larger
proportion of the reads from the libraries prepared with the
SureSelect method (74–75%) than from the ones prepared with
the Nimblegen method (41–67%) aligned to the target regions
(Table 1). The percentage of reads that aligned to the target region
was more consistent between the SureSelect libraries. Thus the
libraries prepared with the SureSelect method showed higher
specificity and better reproducibility than the libraries prepared
with the Nimblegen method.
To avoid bias due to the higher number of sequence reads
obtained from the SureSelect libraries in the subsequent analysis,
we downsampled the reads in the SureSelect libraries to match the
number of reads obtained from the Nimblegen libraries for each
individual and repeated the alignments (Table 1). We then
determined the completeness of coverage of the target region in
the different libraries (Fig. 1). On average, we covered 99.7% of
the regions targeted by the SureSelect probes (Table 2) at least
once, which means that 1.7 Mb (55%) of the original target region
was covered at least once by the 35 bp sequence reads. Of the
regions targeted by the Nimblegen probes we were able to
sequence 98.5% at least once. Thus we were able to sequence
2.3 Mb (76%) of the original target region at least once in the
libraries prepared with the Nimblegen method. The proportion of
the target region that was successfully sequenced at least once
represents the proportion of the target region that we were able to
capture i.e. the completeness of the library. Our results
demonstrate that we obtain higher completeness for SureSelect
libraries when we consider the regions targeted by the method
specific probes. Nimblegen performs almost equally well when the
regions targeted by both probe sets are considered and covers
0.6 Mb more of the original target region. We also looked at the
completeness of coverage of the non-repeated parts of the target
region, as these make up the biologically most relevant target.
Nimblegen performed slightly better in these regions. 98.1% of the
non-repeated part of the target was covered at least once in the
libraries prepared with the Nimblegen method compared to
97.4% in the libraries prepared with the SureSelect method, on
average (data not shown). However the results that we obtained
when looking at the non-repeated part of the target region were
very similar to the region targeted by both probe sets so they are
not reported separately in the further analyses. An example of the
coverage of one of the target genes as well as the positions of the
probes and the repeat elements in both types of libraries is shown
in Figure 2.
We obtained average sequence depths of 59 to 101 for the
Nimblegen libraries and 86 to 113 for the SureSelect libraries after
downsampling (Table 2). To assess the uniformity of the
representation of the targeted regions in the sequencing libraries
in a sequencing depth independent way, we plotted the
normalized coverage for each sample [36] (Fig. 3). We note that
in the SureSelect libraries 67–69% of the targeted bases had at
least half of the average coverage, whereas in the Nimblegen
libraries this number was 61–72%. Thus, on average both
methods performed equally well when judged by the uniformity
of the coverage.
SNP calling and comparison to HapMap positions
In the Nimblegen design, 94–96% of the genotyped SNP
positions from HapMap for each of the three individual samples
fell into the probe targeted regions, whereas 69–75% of the
HapMap SNP positions in each individual sample were in the
probe targeted regions in the Agilent design. 68–74% of the
HapMap SNP positions were in the region targeted by both
methods (Table 3). In total, we called between 2405 and 3371
SNPs per sample requiring a minimum coverage of ten (Table 4).
For each DNA sample, the number of SNPs called was higher in
the library that was prepared using the Nimblegen method than in
the one prepared with the SureSelect method. In the region
targeted by both methods, we called slightly more SNPs in the
libraries that were prepared with the SureSelect method on
average. To compare the base calls in our sequencing data to the
genotypes from HapMap for the three samples that we sequenced,
we made a list of SNP calls obtained using Maq and of base calls at
all the positions that had been genotyped in HapMap and had a
minimum of 10X sequencing coverage in our data for each
sample. Since Maq did not call SNPs in the latter positions, we
assumed that they were equal to the reference sequence. We then
compared our sequencing based genotype list to the HapMap
genotypes for each of the samples (Table 3). We were able to call
73–79% of the HapMap SNPs in the whole target region in the
SureSelect libraries and 85–96% in the Nimblegen libraries. We
correctly called 93–97% of the HapMap SNPs in the regions
targeted by both methods in the SureSelect libraries and 85–94%
Table 1. Sequencing and alignment statistics.
Sample Number of reads (PF)
% of reads that
align to genome
Number of reads that
align to target
% of reads that align
to target
NA10860 SureSelect
(Downsampled)
18 325 890 89 13 803 067 (7603844) 75 (75)
NA10860 Nimblegen 10 093 998 85 5 363 593 53
NA11992 SureSelect
(Downsampled)
18 785 249 90 13 818 498 (9293047) 74 (74)
NA11992 Nimblegen 12 634 643 83 5 209 663 41
NA11993 SureSelect
(Downsampled)
19 148 344 89 14 200 810 (9972236) 74 (74)
NA11993 Nimblegen 13 444 317 88 8 985 107 67
PF = pass filter.
doi:10.1371/journal.pone.0016486.t001
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the HapMap SNPs in the regions targeted by both methods in the
SureSelect libraries, but a greater percentage of the HapMap
SNPs in the whole region of interest and a greater total number of
SNPs in the Nimblegen libraries.
96–98% of the SNPs called in the region targeted by both
methods in the SureSelect libraries and 95–96% in the Nimblegen
libraries were concordant with the HapMap genotypes (Table 3).
The SNP calls, where the position of a SNP agreed, but where the
actual base disagreed with the HapMap SNP data, were further
inspected. Most discrepant calls between the HapMap data and
the SNPs called in our sequences were heterozygous in the
HapMap data, and homozygous according to our sequence data.
We compared the HapMap genotypes and the genotypes obtained
by sequencing from both types of libraries in all the positions
where the sequencing call obtained with either method disagreed
with the HapMap genotype in order to look for allelic drop outs.
We saw more of what appeared to be allelic drop outs in the
libraries prepared with the Nimblegen method in two of the
samples and more allelic drop outs in the SureSelect library in the
third sample. By manual inspection of the alignments we noted
that in almost half of the cases (47% on average) a SNP was
originally correctly called as heterozygous by Maq, but excluded
from our SNP list in the filtering step. In the remaining cases both
alleles were observed by inspecting the alignment manually, but
Maq failed to call both of the SNP alleles. Three positions where
Figure 1. Coverage plots of the sequencing libraries prepared with SureSelect (left) and Nimblegen (right) methods. Cumulative base
frequency is plotted against coverage. In the SureSelect libraries, 94–97% of the bases in the regions targeted by the probes are covered by at least
ten reads. In the Nimblegen libraries the corresponding number is 83–97%.
doi:10.1371/journal.pone.0016486.g001
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PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e16486Figure 2. Coverage of a single gene. Per base coverage plotted along ARL11 in the sample NA11993 in sequencing libraries prepared with
Nimblegen (top) and SureSelect (bottom) methods. The bars at the top of the graph mark the regions that are targeted by probes in each design
(red) and the repeat elements as determined by RepeatMasker (blue).
doi:10.1371/journal.pone.0016486.g002
Table 2. Coverage of the probe targeted regions and regions targeted by both probe sets in each sample.
Sample % probe targeted region/region targeted by both probe sets Average sequencing depth
.1X .10X .30X
NA10860 SureSelect 99.5/99.5 94.4/94.4 83.6/83.4 86
NA10860 Nimblegen 99.0/99.5 93.0/94.8 77.1/80.7 61
NA11992 SureSelect 99.9/99.9 97.4/97.4 88.5/88.5 105
NA11992 Nimblegen 96.9/97.9 83.1/86.3 65.4/70.6 59
NA11993 SureSelect 99.8/99.8 97.3/97.3 88.7/88.7 113
NA11993 Nimblegen 99.5/99.8 96.9/98.0 88.1/90.6 101
doi:10.1371/journal.pone.0016486.t002
Target Enrichment Method Comparison
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but were called heterozygous in the HapMap data, were validated
by Sanger sequencing. Four additional positions that were
homozygous in the HapMap data, but heterozygous in our
sequence data and three positions that were homozygous in the
HapMap data, but homozygous for the opposite allele in our
sequence data were also validated by Sanger sequencing of all
three samples. Of the 12 SNPs that were selected for validation,
one was not sequenced due to failed PCR. In ten cases, the Sanger
sequencing call confirmed our sequencing calls from GAIIx, while
in one case the Sanger sequencing call agreed with the HapMap
data.
Known and novel SNPs in the target region
In addition to comparing our SNP calls to the HapMap
genotypes, we compared them to all the SNPs that were annotated
to our target region in the Ensembl variation database (http://
www.ensembl.org). Out of the SNPs that we called, 90–94% of the
SNP positions per sample matched positions that were already
listed in Ensembl (Table 4). Between 154 and 350 SNPs per
sample appeared to be novel. Twelve of the SNPs that were not
listed in the Ensemble variation database were randomly selected
for validation by Sanger sequencing. Two of the 12 SNPs failed in
the PCR step. In eight cases Sanger sequencing confirmed our
SNP call. In one case the SNP was correctly called as heterozygous
Figure 3. Normalized coverage of the sequencing libraries prepared with SureSelect (left) and Nimblegen (right) methods. To
normalize the coverage, the absolute per base coverage was divided by the mean coverage. In the SureSelect libraries, 67–69% of the regions
targeted by probes are covered by at least half of the average coverage. In the Nimblegen libraries 61–72% of the regions targeted by probes are
covered by at least half of the average coverage.
doi:10.1371/journal.pone.0016486.g003
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library. Manual inspection of the alignment showed that only two
of the 40 reads covering this position in the Nimblegen library
represented the reference allele. The position was thus called
homozygous for the non-reference allele by Maq. One SNP was
called heterozygous in the Nimblegen library, but turned out to be
homozygous by Sanger sequencing, which could be caused by
misalignment of the reads covering this position. The position was
not covered in the corresponding SureSelect library. We then
compared our SNP lists to the 1000 genomes project pilot 1 release
of April 2009 data available at ftp://ftp1.1000genomes.ebi.ac.uk.
91–93% of SNPs per sample matched the SNP positions reported
in the 1000 genomes project data. After excluding all known
positions from Ensembl and the 1000 genomes project, we
identified 67–181 novel SNPs per sample (Table 4 & Supplemen-
tary table S2). In the sample NA10860, 55 of the SNPs were
identified in both SureSelect and Nimblegen libraries. In the
sample NA11992 the corresponding number was 39 and in the
sample NA11993 we identified 79 novel SNPs with both methods.
Between two and 15 of the novel SNPs per sample annotated to
exons, while the remaining novel SNPs were located in introns or
in the 39 or 59 regions of the targeted genes. Out of the ten SNPs
that were successfully sequenced by the Sanger method after
excluding all the SNPs that were annotated in Ensembl variation,
four SNPs were present in the 1000 genomes data and six were
truly novel.
Since the samples that we sequenced here represent two parents
(mother NA11993, father NA11992) and a child (NA10860), we
could test for Mendelian inheritance of the novel SNPs as quality
control to exclude sequencing errors called as SNPs. Using Plink
[41], we analyzed 76 novel SNPs called in the SureSelect libraries
and 108 novel SNPs called in the Nimblegen libraries that were
called in the child and at least one of the parents and were
sequenced to at least ten fold coverage in all three samples. There
were 17 SNPs (22%) that did not follow Mendelian inheritance
when the samples had been prepared using the SureSelect method
and 19 SNPs (18%) when the samples had been prepared using the
Nimblegen method. These results demonstrate that by sequence
capture and sequencing by GAIIx we were able to reliably detect
known SNPs in the targeted region and discover new SNPs even in
the HapMap samples that have been extensively analyzed
previously. Our data further shows that SNP calls obtained from
the SureSelect libraries are more reliable, but we can still call a
larger number of SNPs correctly using the Nimblegen method.
Discussion
Thanks to the rapid and continuous development of the new
generation of sequencing technologies and simultaneous decrease
in sequencing costs, targeted sequencing will likely be used instead
of genotyping in future large scale genetic studies. The aim of our
study was to determine which sequence enrichment method would
Table 3. HapMap SNPs in the targeted region for the three individuals sequenced.
NA10860 NA11992 NA11993
Number of SNPs SureSelect Nimblegen SureSelect Nimblegen SureSelect Nimblegen
In HapMap 977 977 1796 1796 1772 1772
Targeted by probes 673 923 1335 1722 1322 1701
Targeted by both
probe sets
666 666 1323 1323 1310 1310
Covered by sequencing 710 884 1422 1519 1406 1708
Covered by probes
and sequencing
652 870 1328 1498 1307 1678
Covered by both probe
sets and seq
647 635 1317 1189 1297 1293
Sequencing agrees with
HapMap
677 853 1378 1436 1375 1631
Targeted by both probe sets
and seq agrees with HapMap
618 612 1279 1129 1271 1232
doi:10.1371/journal.pone.0016486.t003
Table 4. SNPs in the targeted region and in the region covered by both probe sets.
Total HapMap Annotated in Ensembl In 1000 genomes Novel
NA10860 SureSelect 2 405/2069 232/209 2245/1949 2227/1946 80/66
NA10860 Nimblegen 3 061/2089 310/209 2829/1953 2837/1937 131/87
NA11992 SureSelect 2 513/2161 645/598 2359/2051 2341/2031 67/53
NA11992 Nimblegen 2 598/1821 667/511 2411/1712 2409/1686 92/62
NA11993 SureSelect 2 702/2310 640/591 2453/2125 2483/2145 118/91
NA11993 Nimblegen 3 371/2221 758/556 3021/2031 3079/2049 181/98
doi:10.1371/journal.pone.0016486.t004
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consisted of continuous genomic intervals.
Specificity and uniformity of the capturing process define how
much over-sampling is needed to adequately cover a sequencing
library. In our hands, 54% of the sequence reads aligned to the
targeted region, when the sequencing libraries were prepared
using the Nimblegen method and 74%, when the libraries were
prepared using the SureSelect method, on average. Based on these
percentages we can calculate that if the library is prepared using
the Nimblegen method, approximately 1.4-fold more over-
sampling is required to obtain any given average coverage than
if the library is prepared using the SureSelect method. We
obtained similar uniformity with both methods, which is in
agreement with the results of another study that compared the
same enrichment methods in exonic regions and conserved
elements [42]. Coverage uniformity is important so that one does
not need to waist sequencing capacity for over-sequencing of some
regions in order to obtain adequate coverage of others. As has
been previously shown for hybridization based sequence capture
[42], we obtained high uniformity with both methods.
The major difference between our study and the study by
Teer et al. that concentrated on exons and conserved regions
[42] is that we were able to design Nimblegen probes for 78%
and Agilent probes for 55% of our region of interest, whereas
Teer et al. were able to design probes for 94% and 92.6% of
their region of interest for Nimblegen and Agilent, respectively
[42]. Due to this difference in the probe designs between the two
methods, we recovered a considerably (0.6 Mb) larger propor-
tion of the original target region from the Nimblegen libraries.
To define repeats, Agilent uses RepeatMasker. RepeatMasker
defines repeats according to different criteria than the in-house
algorithm that Nimblegen uses, which explains the differences in
the probe targeted regions between the two methods. We could
recover a slightly larger proportion of the probe targeted regions
from the SureSelect libraries and a slightly larger proportion of
the non-repeated part of the targeted region from the
Nimblegen libraries. This was surprising since Agilent used
RepeatMasker to exclude repeats from the SureSelect design
and we also used RepeatMasker to define the repeats when we
analyzed the non-repeated portion of our target region. It is
likely that the regions, which are included in the Nimblegen
design, but excluded from the SureSelect design, are more
difficult to capture. It would be interesting to compare the two
methods employing the same repeat masking strategy for both
to see how that would influence the results. It is possible to
submit an already RepeatMasked region to Nimblegen for a
design and a custom repeat masking option is currently available
when ordering SureSelect capture probes, but it is dependent on
extra bioinformatics work by the customer. Better coverage of
the whole target region will be increasingly important as the
sequencing read length gets longer and reads can be aligned to
more repeated regions.
We called more known and novel SNPs from the Nimblegen
libraries than from the SureSelect libraries in each sample, which
is expected since we also sequenced a larger proportion of the
target region from those libraries. We observed slightly better
concordance between our SNP calls and the HapMap genotypes
from the SureSelect libraries, which is probably due to the larger
percentage of reads mapping to the targeted region and the
targeted region being smaller in the SureSelect libraries. These
two factors combined lead to higher average coverage in the
SureSelect libraries despite the downsampling of the number of
sequence reads in the SureSelect libraries to equal those in the
Nimblegen libraries in the beginning of the analysis. Our SNP calls
from both types of sequencing libraries correlated very well with
the HapMap genotypes on the individual level reflecting the high
quality of the SNP calls. Ten out of the 11 discrepant calls that
were investigated by Sanger sequencing further agreed with our
sequence data. Our SNP calls also correlated very well with the
data in Ensembl variation as well as with the SNP calls from the
1000 genomes project. In addition to being genotyped by the
HapMap project, the parents of the trio that we sequenced here
are part of the 1000 genomes pilot one cohort of 180 unrelated
individuals that have been sequenced to low coverage. This
explains why we find so few novel SNPs in our samples.
Nevertheless, we do find some new SNPs highlighting the
importance of high coverage sequencing to detect all the variation
in a particular region.
Particularly when a large number of samples are to be
sequenced, practical considerations are important in the choice
of the sequence enrichment method. The SureSelect hybrid
capture protocol is faster and easier to perform than the
Nimblegen protocol, which is a general difference between array
and solution based capture methods rather than between these two
methods in particular. Another advantage of liquid-based capture
methods is that they are easier to multiplex and automate than
array based ones. Multiplexing and automation will become more
important in the future, especially when targeted sequencing is
being used instead of genotyping in studies involving a large
number of samples. Solution based capture methods also require
smaller amounts of input DNA, which is especially important
when clinical samples are studied.
Taken together, our results show that the strengths of the
SureSelect method are better specificity and reproducibility, and
the strength of the Nimblegen method is better overall coverage of
the original target region, which also results in a larger number of
SNP calls per sample. Thus Nimblegen’s method performed better
in discovering variants in our target region. We conclude that
repeat masking and probe design are important parameters when
one wants to capture all the variation in a given region.
Combining the strengths of both methods should be useful in
the further development of sequence capture methods for
massively parallel sequencing in the future.
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